Trial intelligence / Profile preview

PRP vs Hyaluronic Acid for Knee Osteoarthritis

NCT02211521Phase 3Completed

Sponsor
Samsung Medical Center
Start
Aug 2014
Primary completion
Oct 2015
Modality
Adipose-derived MSCs, Bone Marrow MSCs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by Samsung Medical Center. Primary endpoint: International Knee Documentation Committee subjective score at 24 weeks. Started Aug 2014; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02211521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02211521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call